GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXF) » Definitions » Profitability Rank

Sysmex (Sysmex) Profitability Rank : 9 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sysmex Profitability Rank?

Sysmex has the Profitability Rank of 9. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Sysmex's Operating Margin % for the quarter that ended in Dec. 2023 was 17.91%. As of today, Sysmex's Piotroski F-Score is 6.


Competitive Comparison of Sysmex's Profitability Rank

For the Medical Instruments & Supplies subindustry, Sysmex's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Profitability Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Sysmex's Profitability Rank falls into.



Sysmex Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Sysmex has the Profitability Rank of 9. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sysmex's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=141.608 / 790.56
=17.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Sysmex has an F-score of 6 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Sysmex Corp operating margin has been in a 5-year decline. The average rate of decline per year is -3.3%.

4. Consistency of the profitability

5. Predictability Rank


Sysmex Profitability Rank Related Terms

Thank you for viewing the detailed overview of Sysmex's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (Sysmex) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (Sysmex) Headlines

From GuruFocus

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015